DiscoverGloss Angeles"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai
"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai

"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai

Update: 2024-03-15
Share

Description

Heard of "doping" when it comes to SPF? Today you'll learn all about it. Sunscreen is the most important step in your morning skincare routine, but there's still so much confusion around it, as well as challenges brands have to overcome in the US that prohibits us from having more sophisticated UV filters. Sophie Bai, biomedical engineer, cancer drug developer and the founder/CEO of Pavise is our guest today, discussing those challenges in sunscreen development and regulation, the classification of sunscreen as a drug, mislabeling of sunscreens, inaccurate SPF claims, flaws in broad spectrum testing, and what separates Pavise Dynamic Age Defense SPF 30 from other sunscreens.


Shop this episode


GlossAngelesPod.com

https://glossangeles.komi.io

CALL US: 424-341-0426

Shop products from our episodes

Join our FB Group: https://www.facebook.com/groups/glossangelespodcast

Instagram: @glossangelspod, @kirbiejohnson, @saratan

Twitter: @glossangelespod, @kirbiejohnson, @saratan

Email: glossangelespodcast@gmail.com





Hosted on Acast. See acast.com/privacy for more information.

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai

"Doping" in the Sunscreen Industry and the Problem With Broad-Spectrum Testing in the U.S. with Sophie Bai